GSK vs TTWO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

GSK

44.3
AI Score
VS
TTWO Wins

TTWO

58.8
AI Score

Investment Advisor Scores

GSK

44score
Recommendation
HOLD

TTWO

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GSK TTWO Winner
Forward P/E 20.9205 32.5733 GSK
PEG Ratio 18.8322 3.2623 TTWO
Revenue Growth 1.5% 6.1% TTWO
Earnings Growth 8.4% -49.7% GSK
Tradestie Score 44.3/100 58.8/100 TTWO
Profit Margin 17.8% -4.5% GSK
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, TTWO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.